BioSpace News Archive

Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, today announces appointments to its newly established Scientific Advisory Board.

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company’s Chief Executive Officer Yehiel Tal will present at the Dawson James 5th Annual Small Cap Growth Conference on Tuesday, October 29, 2019 at 1:10 p.m. ET

Boehringer Ingelheim today announced the first patient enrolled in its Phase II clinical trial BALANCE-CF™ 1 to evaluate a new treatment for cystic fibrosis.

McCann Health today announced the appointment of Jill Beene as President, McCann Health Echo, a full-service advertising agency solely focused on healthcare professionals and their patients.

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, Inc., a human hematologic product provider, based in Gray, TN.

Quantum Leap Healthcare Collaborative is pleased to announce that co-founder Dr. Laura Esserman will be among the speakers of the first-ever TIME 100 Health Summit, which will convene individuals from the TIME 100 community and prominent figures in healthcare to highlight essential perspectives on health and wellness, and to encourage cross-disciplinary collaboration toward a better, healthier world.

Nextleaf Solutions Ltd. (“Nextleaf”, “OILS”, or the “Company”) (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA), an extraction technology company that owns a portfolio of eight (8) issued and 35 pending patents pertaining to industrial-scale extraction, purification and formulation of cannabinoids, announced today that it has added Dr. Sherry Boodram, former Senior Regulatory Compliance Officer with Health Canada, to its Board of Directors, effective immediately.

Pinelands Recovery Center of Medford, one of the finest, most respected drug and alcohol treatment facilities in New Jersey and part of the Discovery Behavioral Health network, recently announced its partnership with MAP Health Management (“MAP”), the nation’s leading provider of peer-recovery support services and data insights for people with Substance Use Disorders.

Certara®, the global model-informed drug development and decision support leader, today announced that it is celebrating the 20th anniversary of its Simcyp® Consortium.

Patients with chronic shoulder pain have the potential to experience improved range of motion using mirroring techniques in a Virtual Reality (VR) environment, according to a new study